Baguinda, Baby Boy .

HRN: 25-33-08  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2024
CEFOTAXIME 500MG (VIAL)
06/21/2024
06/27/2024
IV
95mg
Q12
Sepsis Neonaturom
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: